Mirikizumab
Drug timelines are a Plus or Pro feature.
44 regulatory and trial events tracked for Mirikizumab, covering 2020-05-29 to 2026-06-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis [Phase 3]